Sai Life Sciences Ltd (SAILIFE)
₹1,232.90
Mkt cap
₹26,174 Cr
P/E ratio
73.80
P/B
10.54
Div yield
0.00%
ROE
15.40%
ROCE
19.60%
EPS (TTM)
₹16.71
Book value
₹117
52W range
788–1,297
Sector
Healthcare
Incorporated in 1999, Sai Life Sciences Ltd carries out contract research and manufacturing activities for customers engaged in pharmaceutical and bio technology industries [1]
Health check
Constructive
ValuationExpensive
ProfitabilityStrong
GrowthHigh
TechnicalsBullish
52-week range
−4.94% from high₹1,233
₹788+56.46% from low₹1,297
Current
₹1,232.90
Prev close
₹1,230.00
Day
+0.24%
Price performance
1D
+0.24%
1W
−4.94%
1M
+0.95%
3M
+20.29%
6M
+50.09%
1Y
+49.75%
YTD
+33.76%
Financials
FRevenue, profit & margin
P/E ratio
73.8×
SAILIFE is 117% above the sector median of 34.0×
SAILIFE73.8×
Sector median34.0×
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 384 | 439 | 280 | 396 | 440 | 580 | 496 | 537 | 556 | 602 | |
| Expenses | 287 | 315 | 254 | 293 | 320 | 422 | 375 | 392 | 369 | 426 | |
| Operating Profit | 96 | 125 | 26 | 102 | 120 | 158 | 121 | 146 | 188 | 177 | |
| OPM % | 25% | 28% | 9% | 26% | 27% | 27% | 24% | 27% | 34% | 29% | |
| Other Income | 11 | 3 | 8 | 10 | 9 | 10 | 10 | 15 | 0 | 16 | |
| Interest | 23 | 21 | 21 | 21 | 23 | 11 | 12 | 9 | 10 | 8 | |
| Depreciation | 31 | 31 | 31 | 36 | 34 | 37 | 38 | 40 | 44 | 45 | |
| Profit before tax | 53 | 76 | -18 | 55 | 72 | 119 | 81 | 112 | 134 | 139 | |
| Tax % | 25% | 26% | -25% | 25% | 25% | 26% | 25% | 25% | 25% | 25% | |
| Net Profit | 40 | 56 | -14 | 42 | 54 | 88 | 60 | 84 | 100 | 104 | |
| EPS in Rs | 2.59 | 4.24 | 2.90 | 4.00 | 4.75 | 4.92 | |||||
| Raw PDF |
Earnings
EResults dates & reactionsNext results
6 Aug '26
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
Avg earnings-day move −0.40% · closed higher next day 3 of last 6
| Q3FY25 | Q4FY25† | Q1FY26 | Q2FY26 | Q3FY26 | Q4FY26 | |
|---|---|---|---|---|---|---|
| Broadcast | 7 Feb '25◦ | 14 May '25◦ | 7 Aug '25◦ | 6 Nov '25◦ | 5 Feb '26◦ | 14 May '26◦ |
| Earnings day | −4.43% | −0.32% | +4.59% | −5.08% | +4.80% | −1.94% |
| +1 day | −9.67% | −0.95% | +12.85% | −1.65% | +10.21% | +0.04% |
| +5 days | −11.10% | −4.73% | +13.72% | −5.46% | +12.83% | +0.12% |
| +15 days | −3.74% | −3.48% | +4.28% | −4.11% | +23.11% | +7.38% |
| +30 days | −1.49% | −1.18% | +12.72% | −0.51% | +21.87% | +10.95% |
| Filing | XBRL | XBRL | XBRL | XBRL | XBRL |
Corporate actions
CLast 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Shareholding
Sas of Jun 202634.53%Promoter
Promoters34.53%0.08
FIIs19.65%1.52
DIIs32.71%1.17
Public13.11%0.42
Ownership trend
Peers
P8 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| Sun Pharma.Inds. | ₹1,941.10 | 37.48 | 4,65,735 | 0.82% | 2,710 | +13.58% | 14,612 | +12.76% | 20.53% |
| Divi's Lab. | ₹7,248.50 | 73.36 | 1,92,425 | 0.41% | 751 | +13.44% | 2,831 | +9.52% | 21.97% |
| Torrent Pharma. | ₹4,961.50 | 86.11 | 1,88,720 | 0.77% | 364 | −20.58% | 4,197 | +41.84% | 15.19% |
| Cipla | ₹1,410.60 | 31.84 | 1,13,955 | 0.92% | 786 | −39.19% | 7,119 | +2.33% | 15.49% |
| Zydus Lifesci. | ₹1,108.70 | 20.38 | 1,10,593 | 0.09% | 1,341 | +21.92% | 7,587 | +16.22% | 21.14% |
| Lupin | ₹2,370.50 | 19.06 | 1,08,387 | 0.76% | 1,469 | +101.49% | 7,475 | +31.89% | 29.93% |
| Mankind Pharma | ₹2,507.20 | 51.44 | 1,03,546 | 0.04% | 559 | +34.23% | 3,443 | +11.81% | 13.53% |
| Sai Life | ₹1,232.90 | 73.75 | 26,174 | 0.00% | 104 | +17.84% | 602 | +3.91% | 19.55% |
| Median: 157 Co. | ₹432.05 | 34.03 | 1,978 | 0.10% | 15 | +28.10% | 176 | +17.66% | 15.10% |
Filings
DAnnual reports1
Concall transcripts17
Credit ratings6
Announcements5
Announcement under Regulation 30 (LODR)-Allotment 10 Jul - Sai Life Sciences allotted 8,900 ESOP shares on 10 July 2026, raising capital by INR 16.81 lakh.Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 7 Jul - Submitted Regulation 74(5) certificates for quarter ended June 30, 2026.Board Meeting Intimation for Notice Of Board Meeting 1 Jul - Board meeting on 06 August 2026 to approve Q1 FY27 unaudited standalone and consolidated results.Closure of Trading Window 25 JunAnnouncement under Regulation 30 (LODR)-Allotment 22 Jun - Sai Life Sciences allotted 1,70,501 shares on 22 June 2026 under ESOP 2008 and MESOP 2018.